...
首页> 外文期刊>International Journal of Pediatrics >IVIG Effects on Erythrocyte Sedimentation Rate in Children
【24h】

IVIG Effects on Erythrocyte Sedimentation Rate in Children

机译:IVIG对儿童红细胞沉降率的影响

获取原文
           

摘要

Background. Erythrocyte sedimentation rate (ESR) is a valuable laboratory tool in evaluation of infectious, inflammatory, and malignant diseases. Red blood cells in outside from the body precipitate due to their higher density than the plasma. In this study we discuss the IVIG effect on ESR in different diseases and different ages.Methods and Materials. Fifty patients under 12 years old who had indication to receive IVIG enrolled in this study. Total dose of IVIG was 2 gr/kg (400 mg/kg in five days or 2 gr/kg in single dose). ESR before infusion of IVIG and within 24 hours after administration of the last dose of IVIG was checked.Results. 23 (46%) patients were males and 27 (54%) were females. The mean of ESR before IVIG was31.8±29.04and after IVIG it was47.2±36.9; this difference was meaningful(P=0.05). Results of ESR changes in different age groups, 6 patients less than 28 days, 13 patients from 1 month to 1 year, 20 patients from 1 to 6 years old, and 11 patients from 6 to 12 years have been meaningful (P=0.001,P=0.025, andP=0.006, resp.).Conclusion. In patients who are receiving IVIG as a therapy, ESR increased falsely (noninflammatory rising); therefore use of ESR for monitoring of response to treatment may be unreliable. Although these results do not apply to neonatal group, we suggest that, in patients who received IVIG, interpretation of ESR should be used cautiously on followup.
机译:背景。红细胞沉降率(ESR)是评估传染性,炎性和恶性疾病的宝贵实验室工具。人体外部的红细胞由于其密度高于血浆而沉淀。在这项研究中,我们讨论了IVIG对不同疾病和不同年龄的ESR的影响。方法和材料。本研究招募了50名12岁以下有接受IVIG指征的患者。 IVIG的总剂量为2µgr / kg(五天为400µmg / kg或单剂为2µgr / kg)。在输注IVIG之前和最后一次输注IVIG后24小时内检查ESR。结果。男性23例(46%),女性27例(54%)。 IVIG之前的ESR平均值为31.8±29.04,IVIG之后的ESR平均值为47.2±36.9;这个差异是有意义的(P = 0.05)。不同年龄组的ESR变化的结果有意义(P = 0.001,13例1个月至1岁,13例1个月至1岁,20例1至6岁,11例6至12岁)。 P = 0.025和P = 0.006,分别)。结论。在接受IVIG疗法的患者中,ESR虚假增加(非炎症性上升)。因此,使用ESR监测治疗反应可能不可靠。尽管这些结果不适用于新生儿组,但我们建议接受IVIG的患者应在随访时谨慎使用ESR的解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号